TOT BIOPHARM International Company Limited (1875.HK)

HKD 1.65

(0.0%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.42 Billion 1.26 Billion 710.26 Million 641.18 Million 1.01 Billion 677.23 Million
Total Current Assets 693.17 Million 676.79 Million 305.96 Million 249.22 Million 614.36 Million 299.68 Million
Cash And Short Term Investments 351.6 Million 458.04 Million 152.8 Million 225.53 Million 571.31 Million 274.08 Million
Cash and Cash Equivalents 351.6 Million 417.76 Million 152.8 Million 225.53 Million 539.18 Million 256.75 Million
Short Term Investments 6.76 Million 40.27 Million 2.57 Million 2.59 Million 32.13 Million 17.33 Million
Net Receivables 140.7 Million 58.4 Million 23.68 Million 2.43 Million 9.19 Million 8.99 Million
Inventory 126 Million 94.82 Million 29.55 Million 8.11 Million 15.25 Million 3.1 Million
Other Current Assets 17 Thousand 38.25 Million 79.86 Million 5.31 Million 43.3 Million 22.49 Million
Total Non-Current Assets 732.92 Million 585.23 Million 404.3 Million 391.95 Million 402.99 Million 377.55 Million
Net PPE 699.22 Million 562.81 Million 365.83 Million 297.74 Million 323.88 Million 316.42 Million
Good Will And Intangible Assets 21.47 Million 4.64 Million 18.45 Million 16.9 Million 16.41 Million 16.26 Million
Good Will - -12.98 Million - - - -
Intangible Assets 21.47 Million 17.63 Million 18.45 Million 16.9 Million 16.41 Million 16.26 Million
Long-Term Investments - -37.09 Million 1.48 Million 8.07 Million -24.14 Million -10.52 Million
Tax Assets - 40.28 Million 18.36 Million 69.12 Million 86.67 Million 55.19 Million
Other Non Current Assets 12.22 Million 14.59 Million 171 Thousand 102 Thousand 176 Thousand 196 Thousand
Other Assets - - - - - -
Total Liabilities 739.41 Million 546.59 Million 375.17 Million 58.82 Million 159.08 Million 861.71 Million
Total Current Liabilities 382.48 Million 275.34 Million 260.8 Million 52.74 Million 146.78 Million 75.13 Million
Account Payables 35.71 Million 25.98 Million 28.21 Million 18 Million - -
Tax Payables 1.65 Million 2.53 Million - - - -
Short Term Debt 42.77 Million 77.05 Million 147.65 Million 1.32 Million 62.77 Million 2.81 Million
Deferred Revenue 299.28 Million 167.59 Million 80.22 Million -1.32 Million - -
Other Current Liabilities 4.71 Million 4.71 Million 4.71 Million 34.73 Million 84.01 Million 72.32 Million
Total Non Current Liabilities 356.92 Million 271.24 Million 114.36 Million 6.08 Million 12.29 Million 786.57 Million
Long-Term Debt 302.87 Million 212.47 Million 60.91 Million 6.08 Million 12.29 Million 12.81 Million
Deferred Revenue Non Current 11 Million 11 Million - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 43.05 Million 58.76 Million 53.45 Million - - 773.76 Million
Other Liabilities - - - - - -
Total Equity 686.68 Million 715.43 Million 335.09 Million 582.35 Million 858.27 Million -184.47 Million
Stock Holders Equity 686.68 Million 713.88 Million 335.09 Million 582.35 Million 858.27 Million -184.47 Million
Common Stock 2.29 Billion 2.29 Billion 1.89 Billion 1.87 Billion 1.87 Billion 537.85 Million
Retained Earnings -1.68 Billion -1.64 Billion -1.59 Billion -1.34 Billion -1.05 Billion -753.78 Million
Accumulated other comprehensive income 72.47 Million 61.91 Million 37.79 Million 49.5 Million 36.92 Million -67.21 Million
Common Stock Equity 686.68 Million 713.88 Million 335.09 Million 582.35 Million 858.27 Million -184.47 Million
Capital Lease Obligation 1.36 Million 1.89 Million 2.59 Million 7.4 Million 15.07 Million 15.12 Million
Total Investments 6.76 Million 3.18 Million 1.48 Million 8.07 Million 7.99 Million 6.81 Million
Total Debt 345.65 Million 289.52 Million 208.56 Million 7.4 Million 75.07 Million 15.62 Million
Net Debt -5.94 Million -128.24 Million 55.76 Million -218.12 Million -464.1 Million -241.12 Million

Balance Sheet Charts